Genetic testing for ovarian or endometrial cancer isn't recommended for everyone. Find out here which patients should be referred for testing.
Table. Risk of cancer if gene mutation is present.
As genetic testing for breast cancer has become more common, women are increasingly interested in genetic testing for other types of gynecologic cancers. As the primary providers of women's health care, OB/GYNs are likely fielding many questions about these tests. Guidance on how to answer some of these questions comes from the Society of Gynecologic Oncology (SGO), which recently released a position statement on who would benefit most from genetic testing based on next generation sequencing technology.
As to who should be tested, the SGO has made the following recommendations.The use of cancer gene panels decreases cost and improves efficiency of cancer genetic testing through reductions in time involved, number of patient visits required, and number of tests sent, the SGO reports. The drawback, however, is that the results are complex and requires the involvement of a cancer genetics professional to help patients and sometimes physicians interpret the results.This technology, using inexpensive, rapid DNA sequencing, can assess a woman's risk for certain gynecologic cancers by identifying whether specific inherited gene mutations are present (Table). These cancer gene panels, which have been available since late 2011, vary in size, with the smallest panel having just 2 genes (eg, BRCA1 and BRCA2) and the largest panels including more than 50 genes.
- Women with a diagnosis of epithelial ovarian, fallopian tube, and peritoneal cancers should receive genetic counseling and be offered genetic testing.
- Women who are unaffected by gynecologic cancer but have a close family member (ie, mother, sister, or daughter) with a diagnosis of ovarian, fallopian tube, or primary peritoneal cancer or who have a family history of ovarian and breast cancer in several relatives should also receive genetic counseling.
- All women with a diagnosis of endometrial cancer should be assessed for Lynch syndrome. This assessment would include a detailed family history of cancer and perhaps specific tests on tissue samples from the cancer lesion.
- Women with a family history of endometrial and colon cancer should receive genetic counseling, regardless of whether they have a cancer diagnosis.
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More